SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-001122
Filing Date
2019-01-29
Accepted
2019-01-29 17:25:33
Documents
8
Period of Report
2019-01-28
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 42087
2 ex4-1.htm EX-4.1 134590
3 ex5-1.htm EX-5.1 12151
4 ex99-1.htm EX-99.1 78504
5 ex99-1_001.jpg GRAPHIC 3212
6 ex99-2.htm EX-99.2 308876
7 ex99-3.htm EX-99.3 13585
8 ex99-4.htm EX-99.4 13732
  Complete submission text file 0001493152-19-001122.txt   609328
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 19549617
SIC: 8071 Services-Medical Laboratories
Assistant Director 9